#TSP TruSpine Technologies PLC – Final Results September 29, 2023 – Posted in: Blog, TruSpine Plc (TSP)

TruSpine Technologies plc, (AQSE: TSP) the medical device company focused on the development of its pioneering “screwless,” spinal (vertebral) stabilisation systems, reports its full year results for the year ended 29 March 2023.   The Company continues to be in a pre-revenue development phase and remains loss making at this stage of its development. The loss before taxation for the year was £853k (2022: £941k) after administrative expenses of £846k (2022: £938k). The R&D tax…

Continue reading

#TSP TruSpine Technologies PLC – Subscription August 15, 2023 – Posted in: Blog, TruSpine Plc (TSP)

TruSpine Technologies plc, (AQSE: TSP) the medical device company focused on the development of its pioneering “screwless,” spinal (vertebral) stabilisation systems announces it has raised gross proceeds of £50,000 through the subscription of 2,000,000 new ordinary shares at a price of 2.5 pence per share (“Subscription Shares”) under its existing share authorities. Admission  Application has been made for the Subscription Shares to be admitted to trading on the Aquis Stock Exchange Growth Market on or…

Continue reading

#VELA investee co. #TSP TruSpine Technologies PLC – Update re Loan May 9, 2023 – Posted in: TruSpine Plc (TSP), Vela Technologies Plc (VELA)

TruSpine Technologies Plc, the medical device company focused on the spinal (vertebral) stabilisation market, announces an update to the announcement released by the Company on 28 February 2023 in relation to the Loan Agreement entered into by the Company.   The announcement of 28 February 2023 omitted to disclose a fixed and floating charge over the Company’s intellectual property to the lender as security for the proceeds of which were received on 27 February 2023.…

Continue reading

#VELA Vela Technologies PLC investee co. #TSP TruSpine Technologies PLC – Further re Bridge Loan Facility February 2, 2023 – Posted in: Vela Technologies Plc (VELA)

TruSpine Technologies Plc, the medical device company focused on the spinal (vertebral) stabilisation market, provides an update in relation to the announcement made on 3 January 2023 concerning the Bridge Loan and LOI entered into with the Investment Group to provide the Company with staged equity funding.   The £200,000 Bridge Loan transfer has experienced delays, however the Company and the Investment Group anticipate that the funds of the Bridge Loan will be received shortly…

Continue reading